2022 - Research.com Best Scientist Award
2022 - Research.com Genetics and Molecular Biology in United States Leader Award
2019 - Distinguished Fellows of the American Association of Immunologists (AAI)
2014 - Fellow, National Academy of Inventors
2009 - AAI Excellence in Mentoring Award, American Association of Immunologists
2002 - AMA Scientific Achievement Award, American Medical Association
2000 - Warren Alpert Foundation Prize For their research that contributed to the development of a drug that effectively treats chronic megelogenous leukemia and other forms of cancer.
1999 - Member of Academia Europaea
1999 - US President's National Medal of Science "For his fundamental discoveries in virology, tumor biology and immunology, notably the discovery of how tumor-causing viruses multiply; for his devotion to building excellence in scientific institutions; and for his statesmanship in fostering communication between scientists and the general public.", Presented by President William Clinton in a White House (East Room) ceremony on Tuesday, March 14, 2000.
1988 - Member of the National Academy of Medicine (NAM)
1987 - Fellow of the Royal Society, United Kingdom
1980 - Fellow of the American Association for the Advancement of Science (AAAS)
1975 - Nobel Prize for their discoveries concerning the interaction between tumour viruses and the genetic material of the cell
1974 - Fellow of the American Academy of Arts and Sciences
1974 - Member of the National Academy of Sciences
1974 - Canada Gairdner International Award
The scientist’s investigation covers issues in Molecular biology, Cell biology, Gene, Transcription factor and Immunology. His Molecular biology research is multidisciplinary, relying on both Cell culture, Gene expression, RNA, DNA and Proto-Oncogene Proteins c-rel. He combines subjects such as Poliovirus and Virology with his study of RNA.
His work focuses on many connections between Cell biology and other disciplines, such as DNA-binding protein, that overlap with his field of interest in MyoD. His Transcription factor research is multidisciplinary, incorporating perspectives in Tumor necrosis factor alpha, Regulation of gene expression and NF-κB. His research in Immunology tackles topics such as microRNA which are related to areas like Immunity.
His primary areas of investigation include Molecular biology, Cell biology, Virology, RNA and Gene. His Molecular biology research is multidisciplinary, incorporating elements of Cell culture, RNA-dependent RNA polymerase, Transcription and Biochemistry, DNA. His work in Cell biology covers topics such as Immunology which are related to areas like Haematopoiesis.
His Virology study incorporates themes from Antibody and Antigen. His RNA study combines topics from a wide range of disciplines, such as Poliovirus and Messenger RNA. His Gene research is under the purview of Genetics.
David Baltimore mainly investigates Cell biology, Immunology, Immune system, Virology and microRNA. His Cell biology research includes themes of T cell, T-cell receptor, Antigen and Regulation of gene expression, Gene. His work carried out in the field of T-cell receptor brings together such families of science as CD8, Molecular biology, Epitope, Major histocompatibility complex and Immunotherapy.
The subject of his Gene research is within the realm of Genetics. His Immunology research incorporates themes from Haematopoiesis and Stem cell. The concepts of his Virology study are interwoven with issues in Dendritic cell, Antibody and Viral vector.
The scientist’s investigation covers issues in Immunology, Cell biology, Immune system, microRNA and Haematopoiesis. His research integrates issues of Viral vector and Virology in his study of Immunology. The study incorporates disciplines such as NFKB1, T cell, T-cell receptor, HEK 293 cells and Macrophage in addition to Cell biology.
His work deals with themes such as Interferon gamma, Immunity, Receptor, Regulation of gene expression and Autoimmunity, which intersect with microRNA. David Baltimore has researched Regulation of gene expression in several fields, including Molecular biology, NF-κB and Transcription factor. David Baltimore has included themes like Tumor necrosis factor alpha, Lipopolysaccharide, Downregulation and upregulation, Messenger RNA and Gene isoform in his Molecular biology study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Amer A. Beg;David Baltimore.
NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
Konstantin D. Taganov;Mark P. Boldin;Kuang-Jung Chang;David Baltimore.
Proceedings of the National Academy of Sciences of the United States of America (2006)
NF-κB: Ten Years After
Patrick A Baeuerle;David Baltimore.
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins
Cornelis Murre;Patrick Schonleber McCaw;David Baltimore.
Multiple nuclear factors interact with the immunoglobulin enhancer sequences.
Ranjan Sen;David Baltimore.
Production of high titer helper-free retroviruses by transient transfection
Warren S. Pear;Garry P. Nolan;Martin L. Scott;David Baltimore.
Proceedings of the National Academy of Sciences of the United States of America (1994)
An inducible transcription factor activates expression of human immunodeficiency virus in T cells
Gary Nabel;David Baltimore.
Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
GQ Daley;RA Van Etten;D Baltimore.
I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
Patrick A. Baeuerle;David Baltimore.
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Ranjan Sen;David Baltimore.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: